市场调查报告书
商品编码
1548167
全球辅助生殖技术市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Assisted Reproductive Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球辅助生殖技术市场需求预计将从2023年的330.5亿美元达到近587亿美元的市场规模,2024-2032年研究期间复合年增长率为6.59%。
辅助生殖技术 (ART) 是指一系列用于解决不孕症和帮助个人怀孕的医疗程序。 ART 包括体外受精 (IVF)、胞浆内单一精子注射 (ICSI) 以及配子或胚胎冷冻保存等技术。这些方法涉及在体外操纵卵子、精子和胚胎,以提高怀孕的机会。 ART 用于传统受孕方法因精子数量低、输卵管阻塞或与年龄相关的生育问题等因素而失败的情况。 ART 领域取得了重大进展,提高了成功率,并为患有不孕症的个人和夫妻提供了新的选择。
生活方式的改变、生育延迟和生殖疾病盛行率上升导致不孕率上升,推动了辅助生殖技术市场的发展。例如,美国生殖医学会强调,全球约有 10-15% 的夫妇患有不孕症。技术进步,例如体外受精技术的改进和基因筛检工具的开发,为提高成功率和个人化治疗提供了新的机会。此外,不同族群对 ART 治疗的认识和接受程度不断提高,也导致需求不断增长。旨在支持不孕症治疗和研究的政府措施和资金进一步促进辅助生殖技术市场的成长。这些驱动因素和机会共同增强了市场发展和创新的潜力。然而,高昂的治疗成本和伦理问题可能会限制辅助生殖技术市场的成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球辅助生殖技术市场的各个细分市场进行了包容性评估。辅助生殖技术产业的成长和趋势为本研究提供了整体方法。
辅助生殖技术市场报告的这一部分提供了国家和区域层面细分市场的详细资料,从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲辅助生殖技术市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。辅助生殖技术市场的主要参与者包括 Cosmos Biomedical、Microm UK Ltd.、Origio (CooperSurgical)、Irvine Scientific、Cryolab Ltd.、Parallabs、欧洲精子库、Bloom IVF 中心。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Assisted Reproductive Technology Market is presumed to reach the market size of nearly USD 58.7 Billion by 2032 from USD 33.05 Billion in 2023 with a CAGR of 6.59% under the study period 2024-2032.
Assisted reproductive technology (ART) refers to a range of medical procedures used to address infertility and assist individuals in conceiving a child. ART encompasses techniques such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and gamete or embryo cryopreservation. These methods involve manipulating eggs, sperm, and embryos outside the body to enhance the chances of pregnancy. ART is employed in cases where traditional conception methods are unsuccessful due to factors like low sperm count, blocked fallopian tubes, or age-related fertility issues. The field of ART has seen significant advancements, improving success rates and providing new options for individuals and couples struggling with infertility.
The assisted reproductive technology market is driven by increasing infertility rates, attributed to lifestyle changes, delayed childbearing, and rising prevalence of reproductive disorders. For instance, the American Society for Reproductive Medicine highlights that infertility affects approximately 10-15% of couples globally. Technological advancements, such as improved IVF techniques and the development of genetic screening tools, offer new opportunities for enhancing success rates and personalizing treatment. Moreover, rising awareness and acceptance of ART treatments across diverse populations contribute to growing demand. Government initiatives and funding aimed at supporting infertility treatments and research further bolster assisted reproductive technology market growth. These drivers and opportunities collectively enhance the potential for market development and innovation. However, high treatment costs and ethical concerns may restrain assisted reproductive technology market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Assisted Reproductive Technology. The growth and trends of Assisted Reproductive Technology industry provide a holistic approach to this study.
This section of the Assisted Reproductive Technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Assisted Reproductive Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Assisted Reproductive Technology market include Cosmos Biomedical, Microm U.K. Ltd., Origio (CooperSurgical), Irvine Scientific, Cryolab Ltd., Parallabs, European Sperm Bank, Bloom IVF Centre. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.